Schedule 13D ownership disclosure
Corvus Pharmaceuticals Inc
Security class unavailable · CUSIP: 221015100
Event date: 2018-01-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 25.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-18-000063
- Form type
- SC 13D
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- Jan 26, 2018
- Reporting period
- Jan 24, 2018
- Description
- Schedule 13D beneficial ownership